180 related articles for article (PubMed ID: 28665498)
21. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats.
Liu F; Liu ZD; Wu N; Cong X; Fei R; Chen HS; Wei L
Liver Transpl; 2009 Sep; 15(9):1092-100. PubMed ID: 19718641
[TBL] [Abstract][Full Text] [Related]
22. Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.
Zhai L; Qiu LY; Zu Y; Yan Y; Ren XZ; Zhao JF; Liu YJ; Liu JB; Qian LX
World J Gastroenterol; 2015 Apr; 21(15):4509-16. PubMed ID: 25914459
[TBL] [Abstract][Full Text] [Related]
23. Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.
Gao JH; Wen SL; Feng S; Yang WJ; Lu YY; Tong H; Liu R; Tang SH; Huang ZY; Tang YM; Yang JH; Xie HQ; Tang CW
Angiogenesis; 2016 Oct; 19(4):501-11. PubMed ID: 27380212
[TBL] [Abstract][Full Text] [Related]
24. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis.
Zhao X; Deng B; Xu XY; Yang SJ; Zhang T; Song YJ; Liu XT; Wang YQ; Cai DY
World J Gastroenterol; 2013 Sep; 19(36):6069-76. PubMed ID: 24106408
[TBL] [Abstract][Full Text] [Related]
25. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
[TBL] [Abstract][Full Text] [Related]
26. Amiloride reduces portal hypertension in rat liver cirrhosis.
Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
[TBL] [Abstract][Full Text] [Related]
27. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
28. Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.
Shibamoto T; Kamikado C; Koyama S
Pflugers Arch; 2008 Jun; 456(3):467-77. PubMed ID: 18193271
[TBL] [Abstract][Full Text] [Related]
29. Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation.
Wang QM; Du JL; Duan ZJ; Guo SB; Sun XY; Liu Z
World J Gastroenterol; 2013 May; 19(19):2921-34. PubMed ID: 23704825
[TBL] [Abstract][Full Text] [Related]
30. 2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis.
Hsin IF; Lee JY; Huo TI; Lee FY; Huang HC; Hsu SJ; Wang SS; Ho HL; Lin HC; Lee SD
J Gastroenterol Hepatol; 2016 May; 31(5):1045-51. PubMed ID: 26474184
[TBL] [Abstract][Full Text] [Related]
31. Anti-fibrotic effects of the Masson pine pollen aqueous extract on hepatic fibrosis rat model.
Cong T; Jin XY; Zhao L; Ma L; Li RS; Zhao P; Guo CJ
Int J Clin Exp Pathol; 2015; 8(5):4651-61. PubMed ID: 26191155
[TBL] [Abstract][Full Text] [Related]
32. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
Vilaseca M; García-Calderó H; Lafoz E; García-Irigoyen O; Avila MA; Reverter JC; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Hepatology; 2017 Jun; 65(6):2031-2044. PubMed ID: 28142199
[TBL] [Abstract][Full Text] [Related]
33. Role of gap junctions modulating hepatic vascular tone in cirrhosis.
Hernández-Guerra M; González-Méndez Y; de Ganzo ZA; Salido E; García-Pagán JC; Abrante B; Malagón AM; Bosch J; Quintero E
Liver Int; 2014 Jul; 34(6):859-68. PubMed ID: 24350605
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.
Guillaume M; Rodriguez-Vilarrupla A; Gracia-Sancho J; Rosado E; Mancini A; Bosch J; Garcia-Pagán JC
J Hepatol; 2013 Feb; 58(2):240-6. PubMed ID: 22989570
[TBL] [Abstract][Full Text] [Related]
35. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
[TBL] [Abstract][Full Text] [Related]
36. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
37. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.
Geerts AM; Vanheule E; Praet M; Van Vlierberghe H; De Vos M; Colle I
Int J Exp Pathol; 2008 Aug; 89(4):251-63. PubMed ID: 18715470
[TBL] [Abstract][Full Text] [Related]
38. Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats.
Kemp W; Kompa A; Phrommintikul A; Herath C; Zhiyuan J; Angus P; McLean C; Roberts S; Krum H
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G762-7. PubMed ID: 19797237
[TBL] [Abstract][Full Text] [Related]
39. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
Hassan MH; Ghobara MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):971-83. PubMed ID: 27245167
[TBL] [Abstract][Full Text] [Related]
40. Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Chang T; Huang HC; Lee FY; Lee SD
Eur J Pharmacol; 2017 May; 802():36-43. PubMed ID: 28238769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
